ArticleInternational journal of retina and vitreous2026
Real-world outcomes after switching to faricimab in previously treated neovascular age-related macular degeneration: longitudinal outcomes up to 24 months.
Daniel Egger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.